Verastem reported $0 in Sales Revenues for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Abbvie ABBV:US $ 14583M 1045M
AstraZeneca AZN:LN 884686.86M 17406.7M
Curis CRIS:US $ 2.39M 0.34M
Cytokinetics CYTK:US $ 88.97M 87.82M
Epizyme EPZM:US $ 27.53M 18.83M
Gilead Sciences GILD:US $ 6260M 330M
Immunogen IMGN:US $ 14.16M 23.92M
Laboratory Of America LH:US $ 3696.9M 202.7M
Novartis NOVN:VX SF 13085M 271M
Pfizer PFE:US $ 27742M 2081M
Roche Holding ROG:VX 16.44B 474M
Tg Therapeutics TGTX:US $ 0.59M 1.42M
Verastem VSTM:US $ 0M 2.6M
YTE INCY:US $ 911.4M 178.16M